The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Medison; Merck Serono; MSD; Novartis/Ipsen; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Medison; Merck Serono; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi; Takeda
Research Funding - Boehringer Ingelheim; Roche
Uncommon EGFR mutations on osimertinib, real-life data (UNICORN study): Updated results, brain efficacy, and resistance mechanisms.
 
Jair Bar
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche/Genentech; Takeda
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Immunai (Inst); MSD (Inst); Novartis (Inst); Oncohost (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Nir Peled
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Imagene AI; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Pfizer (Inst); Roche/Genentech (Inst)
 
Shiruyeh Schokrpur
Consulting or Advisory Role - MJH Life Sciences
 
Elizabeth Dudnik
No Relationships to Disclose
 
Mira Wollner
Honoraria - AstraZeneca; Merck Sharp & Dohme
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche Israel (Inst); takeda
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche Israel
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer
 
Nicolas Girard
Employment - AstraZeneca (I)
Consulting or Advisory Role - AMGEN; AstraZeneca; Bristol-Myers Squibb; Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); BMS (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Frank Aboubakar Nana
No Relationships to Disclose
 
Sofie Derijcke
No Relationships to Disclose
 
Waleed Kian
No Relationships to Disclose
 
Sandip P. Patel
No Relationships to Disclose
 
Hadas Yocheved Gantz Sorotsky
No Relationships to Disclose
 
Alona Zer
Stock and Other Ownership Interests - Nixio
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; MSD; Oncotest/Rhenium; Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche
 
Mor Moskovitz
No Relationships to Disclose
 
Giulio Metro
No Relationships to Disclose
 
Yakir Rottenberg
Consulting or Advisory Role - AstraZeneca; Bayer; Medison; MSD; Novartis; Novartis; Roche; Takeda; Takeda
Speakers' Bureau - AstraZeneca; Medison; MSD; Roche
Research Funding - AstraZeneca; MSD
Patents, Royalties, Other Intellectual Property - Name: BIOACTIVE PHENOL METAL COMPLEXES Provisional Patent 62/834,717 filed in 16/04/2019 (Yissum Ref. No. 6607-00) Inventor: Abraham Jacob DombPI, Noam SteinmanPI, Yakir RottenbergC Stage: provisional (no country designation yet) Status: commercialized
Travel, Accommodations, Expenses - Pfizer
 
Antonio Calles
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Sanofi/Regeneron; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; IGEN BIOTECH; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Sanofi/Regeneron; Takeda
Research Funding - MSD Oncology
 
Maximilian Hochmair
No Relationships to Disclose
 
Kristof Cuppens
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; MSD; Pfizer; Roche/Genentech
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche/Genentech
 
Lynn Decoster
No Relationships to Disclose
 
Alfredo Addeo
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bristol Myers Squibb Foundation; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca/MedImmune; Lilly
Travel, Accommodations, Expenses - Roche; Takeda